Company profile BYSI

BeyondSpring Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 17:50:09.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
BeyondSpring expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201944
26
-40.9% QoQ
65
150.0% QoQ
63
-3.1% QoQ
2020 39
-11.4% YoY -38.1% QoQ
58
123.1% YoY 48.7% QoQ
62
-4.6% YoY 6.9% QoQ
94
49.2% YoY 51.6% QoQ
2021 101
159.0% YoY 7.4% QoQ
55
-5.2% YoY -45.5% QoQ
236
280.6% YoY 329.1% QoQ
129
37.2% YoY -45.3% QoQ
2022 103
2.0% YoY -20.2% QoQ
39
-29.1% YoY -62.1% QoQ
35
-85.2% YoY -10.3% QoQ
50
-61.2% YoY 42.9% QoQ
2023 47
-54.4% YoY -6.0% QoQ
29
-25.6% YoY -38.3% QoQ
34
-2.9% YoY 17.2% QoQ
59
18.0% YoY 73.5% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and BeyondSpring search interest

There is not enough data for BeyondSpring to provide correlation calculation

Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:50:10.

The average 5 years interest of BeyondSpring was 5.24 per week.
The last year interest of BeyondSpring compared to the last 5 years has changed by -44.66%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -30.12%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 17:50:15.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Plinabulin expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201999
139
40.4% QoQ
154
10.8% QoQ
28
-81.8% QoQ
2020 64
-35.4% YoY 128.6% QoQ
57
-59.0% YoY -10.9% QoQ
97
-37.0% YoY 70.2% QoQ
170
507.1% YoY 75.3% QoQ
2021 148
131.2% YoY -12.9% QoQ
87
52.6% YoY -41.2% QoQ
110
13.4% YoY 26.4% QoQ
185
8.8% YoY 68.2% QoQ
2022 104
-29.7% YoY -43.8% QoQ
170
95.4% YoY 63.5% QoQ
83
-24.5% YoY -51.2% QoQ
34
-81.6% YoY -59.0% QoQ
2023 44
-57.7% YoY 29.4% QoQ
109
-35.9% YoY 147.7% QoQ
284
242.2% YoY 160.6% QoQ
73
114.7% YoY -74.3% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Plinabulin search interest

There is not enough data for Plinabulin to provide correlation calculation

Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:50:16.

The average 5 years interest of Plinabulin was 8.58 per week.
The last year interest of Plinabulin compared to the last 5 years has changed by 8.51%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 10.05%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BeyondSpring cancer therapy to provide analysis

Correlation between past revenue and BeyondSpring cancer therapy search interest

There is not enough data for BeyondSpring cancer therapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BeyondSpring cancer therapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Plinabulin clinical trials to provide analysis

Correlation between past revenue and Plinabulin clinical trials search interest

There is not enough data for Plinabulin clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Plinabulin clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Immuno-oncology agents to provide analysis

Correlation between past revenue and Immuno-oncology agents search interest

There is not enough data for Immuno-oncology agents to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Immuno-oncology agents to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BeyondSpring stock price to provide analysis

Correlation between past revenue and BeyondSpring stock price search interest

There is not enough data for BeyondSpring stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BeyondSpring stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BeyondSpring hiring to provide analysis

Correlation between past revenue and BeyondSpring hiring search interest

There is not enough data for BeyondSpring hiring to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BeyondSpring hiring to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Plinabulin patient reviews to provide analysis

Correlation between past revenue and Plinabulin patient reviews search interest

There is not enough data for Plinabulin patient reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Plinabulin patient reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BeyondSpring cancer survivor stories to provide analysis

Correlation between past revenue and BeyondSpring cancer survivor stories search interest

There is not enough data for BeyondSpring cancer survivor stories to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BeyondSpring cancer survivor stories to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BeyondSpring -stock -company to provide analysis

Correlation between past revenue and BeyondSpring -stock -company search interest

There is not enough data for BeyondSpring -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BeyondSpring -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for BYSI
Earnings date: 2024-02-28
Company name: BeyondSpring Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T11:00:00Z

GlobeNewswire
BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update

2026-04-22T11:00:00Z

GlobeNewswire
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs

2026-03-30T11:30:00Z

GlobeNewswire
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026

2026-03-25T20:30:00Z

GlobeNewswire
BeyondSpring Files 2025 Annual Report on Form 10-K

2026-03-25T12:30:00Z

GlobeNewswire
BeyondSpring Reports 2025 Year-End Financial Results

2026-02-09T12:15:00Z

GlobeNewswire
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference

2025-12-12T12:00:00Z

GlobeNewswire
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path

2025-12-11T12:00:00Z

GlobeNewswire
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025

2025-11-12T12:00:00Z

GlobeNewswire
BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update

2025-10-15T20:07:14-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - BeyondSpring Inc. (0001677940) (Issuer)

2025-10-10T17:58:02-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - BeyondSpring Inc. (0001677940) (Issuer)

2025-10-07T18:14:58-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - BeyondSpring Inc. (0001677940) (Issuer)

2025-10-02T20:51:46-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - BeyondSpring Inc. (0001677940) (Issuer)

2025-09-29T20:06:37-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - BeyondSpring Inc. (0001677940) (Issuer)

2025-09-24T18:49:10-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - BeyondSpring Inc. (0001677940) (Issuer)